What Causes High Intraocular Pressure and Who’s at Risk?

High intraocular pressure happens when fluid builds up inside your eye faster than it can drain out. Normal eye pressure falls between 10 and 20 millimeters of mercury (mmHg), and pressure consistently above that range is called ocular hypertension. The causes range from subtle, age-related changes in your eye’s drainage system to medications, anatomical features, and systemic health conditions.

How Fluid Balance Controls Eye Pressure

Your eye constantly produces a clear fluid called aqueous humor, which nourishes the lens and cornea and then drains away to maintain a stable internal pressure. About 80% to 90% of this fluid is actively pumped into the eye by tissue behind the iris, using an energy-dependent process similar to how your kidneys filter blood. The remaining 10% to 20% seeps in passively through diffusion and filtration.

Once the fluid has done its job, it exits through two routes near the front of the eye. The primary route, handling roughly 75% of drainage, passes through a sponge-like tissue called the trabecular meshwork and into a tiny channel (Schlemm’s canal), which feeds into small veins on the eye’s surface. A secondary route allows fluid to seep through the muscle tissue behind the iris and out through the white of the eye. When either of these drainage pathways meets increased resistance, or when the balance between production and drainage tips, pressure rises.

Gradual Drainage Decline

The most common cause of chronically elevated eye pressure is a slow deterioration of the trabecular meshwork, the primary drainage tissue. Over years, this tissue can become less efficient for several reasons: accumulated debris clogs the spaces between cells, the number of drainage cells decreases, the tiny pores in the canal lining shrink in both size and number, and the tissue loses its ability to clean itself through normal cellular “housekeeping.” Oxidative damage, abnormal immune responses, and shifts in hormone-like signaling within the meshwork all contribute.

This gradual process is the hallmark of primary open-angle glaucoma, the most prevalent form of glaucoma worldwide. Because the drainage angle between the iris and cornea stays physically open, there’s no sudden blockage. Pressure creeps up over months or years, often without symptoms, which is why routine eye exams matter so much for catching it early.

Sudden Blockage of the Drainage Angle

In some eyes, the space between the iris and the cornea is naturally narrow. When the pupil dilates to a mid-range position, the iris can press against the lens and block fluid from flowing forward into the drainage area. Fluid trapped behind the iris pushes the peripheral iris forward like a billowing curtain, sealing off the drainage angle entirely. This is called acute angle closure, and it can send eye pressure soaring within hours, causing severe pain, blurred vision, and nausea.

Several factors make this more likely. People who are farsighted tend to have smaller eyes with narrower angles. A thickening lens, which happens naturally with age, crowds the space further. Certain medications that dilate the pupil, including some cold remedies, antihistamines, and drugs used during eye exams, can trigger an episode in someone with a predisposed anatomy. A thicker-than-average iris or an unusual iris shape called plateau iris configuration also increases risk.

Medications That Raise Eye Pressure

Corticosteroids are the best-documented medication trigger. Whether delivered as eye drops, inhaled for asthma, taken orally, or even applied as a skin cream near the eyes, steroids can raise intraocular pressure by remodeling the drainage tissue at a microscopic level. They cause abnormal proteins and structural fibers to accumulate in and around the meshwork, stiffen the cellular scaffolding, and reduce the tissue’s ability to clear debris. The net effect is increased resistance to fluid outflow.

Not everyone responds the same way. When treated with steroid eye drops for four to six weeks, about 5% of the general population experiences a large pressure spike of more than 16 mmHg, while roughly 30% see a moderate rise of 6 to 15 mmHg. People who already have glaucoma are far more sensitive: over 90% of open-angle glaucoma patients show a significant pressure increase after just four weeks on potent steroid drops. The pressure rise is typically reversible once the steroid is stopped, but prolonged, unmonitored use can cause lasting damage.

Conditions That Clog the Drainage System

Several eye conditions physically obstruct the drainage pathway with material that doesn’t belong there.

In pseudoexfoliation syndrome, tiny flakes of protein fiber, sometimes described as resembling microscopic dandruff, are produced throughout the body and accumulate inside the eye. Over time, this material collects in the drainage angle between the iris and cornea, raising pressure and increasing the risk of optic nerve damage. Pseudoexfoliation is one of the most common identifiable causes of secondary open-angle glaucoma, particularly in people of Scandinavian or Mediterranean descent.

A related condition called pigment dispersion syndrome involves granules of pigment shed from the back surface of the iris. These granules wash into the drainage meshwork and clog it, much like sediment blocking a filter. This tends to affect younger, nearsighted individuals and can cause intermittent pressure spikes, especially after exercise or pupil dilation.

Systemic Health Connections

Conditions elsewhere in your body can influence eye pressure or amplify the damage it causes. Obstructive sleep apnea has drawn significant research attention. A large study of over 4.5 million patients found that people with sleep apnea had a 40% higher risk of developing glaucoma. Interestingly, researchers initially expected elevated eye pressure to be the link, since chest pressure rises when breathing stops during sleep. But eye pressure actually dropped during apnea episodes. The current thinking is that repeated drops in blood oxygen levels, a direct consequence of interrupted breathing, may damage the optic nerve independently of pressure.

High blood pressure, diabetes, and conditions affecting blood flow to the eye have also been associated with elevated intraocular pressure or with a higher likelihood of pressure-related nerve damage, though the relationships are complex and vary between individuals.

Who Is Most at Risk

Age is the single strongest demographic risk factor. The risk of both elevated eye pressure and glaucoma roughly doubles with each decade of life, largely because the drainage system becomes less efficient over time and the lens thickens, narrowing the drainage angle.

Family history plays a meaningful role. Having a first-degree relative (parent or sibling) with glaucoma nearly doubles your odds of developing it. Research from the Los Angeles Latino Eye Study found that older age, male sex, and family history were all independent risk factors, meaning each one raises risk on its own regardless of the others. Native American ancestry and African descent are also associated with higher rates of ocular hypertension and glaucoma, while people of East Asian descent face higher rates of angle-closure disease.

High Pressure Does Not Always Mean Glaucoma

Elevated eye pressure is the most significant known risk factor for glaucoma, but it is not the same thing as glaucoma. Many people walk around with pressures above 20 mmHg for years without developing any optic nerve damage. The landmark Ocular Hypertension Treatment Study tracked people with elevated pressure who received no treatment and found that 9.5% developed glaucoma within five years and 22% within thirteen years, roughly a 2% annual conversion rate. That means the majority of untreated people with high eye pressure did not progress to glaucoma over more than a decade.

When monitoring elevated pressure, eye care providers look at the optic nerve for signs of cupping (a characteristic hollowing), measure the thickness of nerve fiber layers using imaging scans, and test peripheral vision for blind spots. The initial treatment goal for people who do need intervention is typically a 20% to 30% reduction from their baseline pressure, adjusted over time based on whether damage is progressing. Treatment usually starts with pressure-lowering eye drops, with laser procedures or surgery reserved for cases that don’t respond adequately.